Eunkyung Park

Eunkyung Park, MD, PhD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Salt Lake City
801-585-0100

  • Specialties

    Board Certification

    American Board of Nuclear Medicine
    Educational Commission for Foreign Medical Graduates
    Korean Board of Nuclear Medicine

  • Board Certification and Academic Information

    Academic Departments Radiology & Imaging Sciences -Primary
    Board Certification
    American Board of Nuclear Medicine
    Educational Commission for Foreign Medical Graduates
    Korean Board of Nuclear Medicine

    Education history

    Chief Resident Nuclear Medicine - University of Iowa Hospitals and Clinics Chief Resident
    Nuclear Medicine - University of Iowa Hospitals and Clinics Resident
    Research Fellow Molecular Neuroimaging, Nuclear Medicine - University at Buffalo School of Medicine and Biomedical Sciences Research Fellow
    Nuclear Medicine - Korea University Anam Hospital Clinical Fellow
    Chief Resident Nuclear Medicine - Seoul National University Hospital Chief Resident
    Nuclear Medicine - Seoul National University College of Medicine Ph.D.
    Residency Nuclear Medicine - Seoul National University Hospital Resident
    Preliminary Year - Seoul National University Hospital Intern
    Professional Medical Medicine - Seoul National University College of Medicine M.D.

    Selected Publications

    Journal Article

    1. Baldassarri SR, Park E, Finnema SJ, Planeta B, Nabulsi N, Najafzadeh S, Ropchan J, Huang Y, Hannestad J, Maloney K, Bhagwagar Z, Carson RE (2020). Inverse changes in raphe and cortical 5-HT1B receptor availability after acute tryptophan depletion in healthy human subjects. Synapse, 74(10), e22159. (Read full article)
    2. Kwon Y, Park E, Pahk K, Kim S, Kim MJ, Graf D, Park S (2019). Preoperative assessment of malignant potential of gastrointestinal stromal tumor by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging: Usefulness of standardized uptake value and retention index. J Cancer Res Ther, 15(1), 142-147. (Read full article)
    3. Park E, Hwang YM, Chu MK, Jung KY (2015). Increased Brainstem Serotonergic Transporter Availability in Adult Migraineurs: an [(18)F]FP-CIT PET Imaging Pilot Study. Nucl Med Mol Imaging, 50(1), 70-5. (Read full article)
    4. Park E, Sullivan JM, Planeta B, Gallezot JD, Lim K, Lin SF, Ropchan J, McCarthy TJ, Ding YS, Morris ED, Williams WA, Huang Y, Carson RE (2015). Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humans. Eur J Nucl Med Mol Imaging, 42(10), 1530-41. (Read full article)
    5. Park E, Gallezot JD, Delgadillo A, Liu S, Planeta B, Lin SF, OConnor KC, Lim K, Lee JY, Chastre A, Chen MK, Seneca N, Leppert D, Huang Y, Carson RE, Pelletier D (2015). (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas. Eur J Nucl Med Mol Imaging, 42(7), 1081-92. (Read full article)
    6. Park E, Hwang YM, Lee CN, Kim S, Oh SY, Kim YC, Choe JG, Park KW (2013). Differential Diagnosis of Patients with Inconclusive Parkinsonian Features Using [(18)F]FP-CIT PET/CT. Nucl Med Mol Imaging, 48(2), 106-13. (Read full article)
    7. Kim YC, Kim YH, Um SH, Seo YS, Park EK, Oh SY, Han YM, Choe JG (2010). Usefulness of Bremsstrahlung Images after Intra-arterial Y-90 Resin Microphere Radioembolization for Hepatic Tumors. Nucl Med Mol Imaging, 45(1), 59-67. (Read full article)
    8. Kim YC, Kim YH, Uhm SH, Seo YS, Park EK, Oh SY, Jeong E, Lee S, Choe JG (2010). Radiation safety issues in Y-90 microsphere selective hepatic radioembolization therapy: possible radiation exposure from the patients. Nucl Med Mol Imaging, 44(4), 252-60. (Read full article)
    9. Lee SR, Park EK, Won NH, Kim BS (2010). Esophageal involvement by extranodal natural killer T cell lymphoma, nasal type, mimicking Ebstein Barr viral esophagitis in a tonsillar lymphoma patient undergoing chemoradiation therapy. Asia Pac J Clin Oncol, 6(3), 149-54. (Read full article)
    10. Chung SY, Lee KY, Chun EJ, Lee WW, Park EK, Chang HJ, Choi SI (2010). Comparison of stress perfusion MRI and SPECT for detection of myocardial ischemia in patients with angiographically proven three-vessel coronary artery disease. AJR Am J Roentgenol, 195(2), 356-62. (Read full article)
    11. Han YM, Kim YC, Park EK, Choe JG (2010). Diagnostic value of CT density in patients with diffusely increased FDG uptake in the thyroid gland on PET/CT images. AJR Am J Roentgenol, 195(1), 223-8. (Read full article)
    12. Park EK, Lee SR, Kim YC, Oh SY, Choe JG (2010). Peritoneal Lymphomatosis Imaged by F-18 FDG PET/CT. Nucl Med Mol Imaging, 44(2), 159-60. (Read full article)
    13. Park JH, Park EK, Kang CH, Kim CH, Choe JG, Noh W (2009). Intense accumulation of 18F-FDG, not enhancement on MRI, helps to guide the surgical biopsy accurately in soft tissue tumors. Ann Nucl Med, 23(10), 887-9. (Read full article)
    14. Lee Y, Pyun SB, Park EK, Youn SW (2009). Persistent dysarthria after cefazolin-induced status epilepticus. Brain Inj, 23(10), 846-51. (Read full article)
    15. Park EK, Chung JK, Lim IH, Park DJ, Lee DS, Lee MC, Cho BY (2008). Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans. Eur J Nucl Med Mol Imaging, 36(2), 172-9. (Read full article)
    16. Lee WW, Park EK, Eo JS, Lee SW, Kim CH, So Y, Lee DS, Chung JK, Lee MC, Kim SE (2005). Evaluation of immediate post-stress wall motion on adenosine stress/rest thallium-201 gated myocardial SPECT. Int J Cardiovasc Imaging, 22(2), 213-22. (Read full article)

    Review

    1. Park E, Graves S, Menda Y (2022). The Impact of Radiopharmaceutical Therapy on Renal Function. [Review]. Semin Nucl Med, 52(4), 467-474. (Read full article)
    2. Park E (2012). A new era of clinical dopamine transporter imaging using 123I-FP-CIT. [Review]. J Nucl Med Technol, 40(4), 222-8. (Read full article)

  • News & Podcasts